(S1 (S (S (NP (NP (NN Apoptosis)) (VP (VBN induced) (PP (IN by) (NP (NP (NN 1'-acetoxychavicol) (NN acetate)) (PP (IN in) (NP (NN Ehrlich) (NNS ascites) (NP (NN tumor) (NNS cells)))))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN modulation)) (PP (IN of) (NP (NP (NN polyamine) (NN metabolism)) (CC and) (NP (NN caspase-3) (NN activation))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN efficacy)) (PP (IN of) (NP (NP (DT the) (JJ antitumor) (NN activity)) (PP (IN of) (NP (NP (NP (NN 1'-acetoxychavicol) (NN acetate)) (PRN (-LRB- -LRB-) (NP (NN ACA)) (-RRB- -RRB-))) (, ,) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (NN suppressor)) (PP (IN of) (NP (ADJP (RB chemically) (VBN induced)) (NN carcinogenesis)))))))) (, ,)))))) (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (NN Ehrlich) (NNS ascites) (NP (NN tumor) (NNS cells))))))) (. .)))
(S1 (S (S (NP (NN ACA) (NN treatment)) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (NNS changes)) (PP (IN in) (NP (NN morphology)))) (CC and) (NP (NP (DT a) (JJ dose-dependent) (NN suppression)) (PP (IN of) (NP (NN cell) (NN viability)))))))) (. .)))
(S1 (S (S (NP (NP (NN Apoptosis)) (, ,) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ nuclear) (NN condensation)) (, ,) (NP (NN membrane) (NN blebbing)) (, ,) (NP (NN cell) (NN shrinkage)) (CC and) (NP (NP (DT a) (JJ significant) (NN induction)) (PP (IN of) (NP (JJ caspase-3-like) (NN protease) (NN activity))) (PP (IN at) (NP (CD 8) (NN h))) (PP (IN in) (NP (DT a) (JJ time-course) (NN study)))))))) (VP (VBD were) (VP (VBN observed)))) (. .)))
(S1 (S (S (NP (NP (NN Formation)) (PP (IN of) (NP (JJ apoptotic) (NNS bodies)))) (VP (VBD was) (VP (VBN preceded) (PP (IN by) (NP (NP (NN lowering)) (PP (IN of) (NP (NP (JJ intracellular) (NNS polyamines)) (, ,) (ADVP (RB particularly)) (NP (NP (NN putrescine)) (, ,) (CC and) (NP (CC both) (NP (NN dose-)) (CC and) (NP (NP (JJ time-dependent) (JJ inhibitory) (CC and) (NN activation) (NN effect)) (PP (IN by) (NP (NN ACA))) (PP (IN on) (NP (NP (NP (NN ornithine) (NN decarboxylase)) (PRN (-LRB- -LRB-) (NP (NN ODC)) (-RRB- -RRB-))) (CC and) (NP (NP (NN spermidine/spermine) (NN N-LRB-1-RRB--acetyltransferase)) (PRN (-LRB- -LRB-) (NP (NN SSAT)) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively)))))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (JJ exogenous) (NNS polyamines)))) (VP (VP (VBD prevented) (NP (NP (JJ ACA-induced) (NN apoptosis)) (VP (VBN represented) (PP (IN by) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ apoptotic) (NNS bodies)))))))))) (CC and) (ADVP (RB also)) (VP (VBD caused) (NP (NP (NN reduction)) (PP (IN in) (NP (DT the) (VBN induced) (JJ caspase-3-like) (NN protease) (NN activity)))) (PP (IN at) (NP (CD 8) (NN h)))))) (. .)))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ anticarcinogenic) (NNS effects)) (PP (IN of) (NP (NN ACA)))) (VP (MD might) (VP (VB be) (ADJP (RB partly) (JJ due) (PP (TO to) (NP (NP (NP (NN perturbation)) (PP (IN of) (NP (DT the) (NN polyamine) (JJ metabolic) (NN pathway)))) (CC and) (NP (NP (NN triggering)) (PP (IN of) (NP (NP (JJ caspase-3-like) (NN activity)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP result) (PP (IN in) (NP (NN apoptosis)))))))))))))))))) (. .)))
